In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 14161-11-6, name is 3,4,5-Trichloropyridazine, introducing its new discovery. SDS of cas: 14161-11-6
This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Abeta related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 14161-11-6, and how the biochemistry of the body works.SDS of cas: 14161-11-6
Reference:
Pyridazine – Wikipedia,
Pyridazine | C4H4N2491 – PubChem